[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
An evaluation of the therapeutic efficacy of Amisulpride as compared with Viloxazine in a group of patients diagnosed as dysthymic, according to the DSM-III-R criteria is presented. Study was a double-blind, randomized controlled trial: Subjects were assessed during an initial examination with informed consent, then entering a 4-week treatment trial. The Hamilton Depression Scale, the Widlocher Psychomotor Retardation Scale, and the Andreasen Negative Symptoms Scale were used for evaluating cases. Both the efficacy and safety of drugs were assessed. An analysis of results suggests a better therapeutic response among the Amisulpride group subjects.
León
C A
CA
Departamento de Psiquiatría, Facultad de Salud, Universidad del Valle, Cali, Colombia.
Vigoya
J
J
Conde
S
S
Campo
G
G
Castrillón
E
E
León
A
A
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000077582:Amisulpride; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D017678:Sex Distribution; D012959:Socioeconomic Factors; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014745:Viloxazine / Q000009:adverse effects / Q000627:therapeutic use*
D011619:Psychotropic Drugs; D014745:Viloxazine; D013469:Sulpiride; D000077582:Amisulpride
Comparación del efecto de la amisulprida y la viloxacina en el tratamiento de la distimia.